|
1
|
Fan NJ, Kang R, Ge XY, Li M, Liu Y, Chen
HM and Gao CF: Identification alpha-2-HS-glycoprotein precursor and
tubulin beta chain as serology diagnosis biomarker of colorectal
cancer. Diagn Pathol. 9:532014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parkin DM, Pisani P and Ferlay J: Global
cancer statistics. CA Cancer J Clin. 49:33–64, 31. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kinzler KW and Vogelstein B: Lessons from
hereditary colorectal cancer. Cell. 87:159–170. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fearon ER and Vogelstein B: A genetic
model for colorectal tumorigenesis. Cell. 61:759–767. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tsuchiya K: Remodeling of cancer stem
cells in gastrointestinal cancer. Nihon Rinsho. 73:855–859.
2015.PubMed/NCBI
|
|
6
|
Kim JT, Song EY, Chung KS, Kang MA, Kim
JW, Kim SJ, Yeom YI, Kim JH, Kim KH and Lee HG: Up-regulation and
clinical significance of serine protease kallikrein 6 in colon
cancer. Cancer. 117:2608–2619. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xie Y, Yu F, Tang W, Alade BO, Peng ZH,
Wang Y, Li J and Oupický D: Synthesis and evaluation of
chloroquine-containing DMAEMA copolymers as efficient anti-miRNA
delivery vectors with improved endosomal escape and antimigratory
activity in cancer cells. Macromol Biosci. 18:2018.doi:
10.1002/mabi.201700194. View Article : Google Scholar
|
|
8
|
Zeng Y, Wang KX, Xu H and Hong Y:
Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3,
and hsa-miR-600 as potential prognostic biomarker for cervical
cancer. J Cell Biochem. 119:1558–1566. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Barh D, Malhotra R, Ravi B and Sindhurani
P: MicroRNA let-7: An emerging next-generation cancer therapeutic.
Curr Oncol. 17:70–80. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cohen RJ, Dennis LH and Conrad ME:
Anticoagulant therapy in chronic idiopathic thrombocytopenic
purpura. Blood. 31:647–652. 1968.PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sells E, Pandey R, Chen H, Skovan BA, Cui
H and Ignatenko NA: Specific microRNA-mRNA regulatory network of
colon cancer invasion mediated by tissue kallikrein-related
peptidase 6. Neoplasia. 19:396–411. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim TW, Lee SJ, Kim JT, Kim SJ, Min JK,
Bae KH, Jung H, Kim BY, Lim JS, Yang Y, et al: Kallikrein-related
peptidase 6 induces chemotherapeutic resistance by attenuating
auranofin-induced cell death through activation of autophagy in
gastric cancer. Oncotarget. 7:85332–85348. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kaback HR: The role of the
phosphoenolpyruvate-phosphotransferase system in the transport of
sugars by isolated membrane preparations of Escherichia coli. J
Biol Chem. 243:3711–3724. 1968.PubMed/NCBI
|
|
15
|
Quarles RH, Shin ML and Waksman BH: A
workshop on mechanisms of myelin breakdown. Ann Neurol. 19:971986.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Elbrønd H, Huniche B and Ostergaard L:
Rabbit sphincter of Oddi and duodenum are regulated by slow waves
with a common basic-mode activity. Scand J Gastroenterol.
25:534–540. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nagahara H, Mimori K, Utsunomiya T,
Barnard GF, Ohira M, Hirakawa K and Mori M: Clinicopathologic and
biological significance of kallikrein 6 overexpression in human
gastric cancer. Clin Cancer Res. 11:6800–6806. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ni X, Zhang W, Huang KC, Wang Y, Ng SK,
Mok SC, Berkowitz RS and Ng SW: Characterisation of human
kallikrein 6/protease M expression in ovarian cancer. Br J Cancer.
91:725–731. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tamir A, Jag U, Sarojini S, Schindewolf C,
Tanaka T, Gharbaran R, Patel H, Sood A, Hu W, Patwa R, et al:
Kallikrein family proteases KLK6 and KLK7 are potential early
detection and diagnostic biomarkers for serous and papillary serous
ovarian cancer subtypes. J Ovarian Res. 7:1092014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pampalakis G, Prosnikli E, Agalioti T,
Vlahou A, Zoumpourlis V and Sotiropoulou G: A tumor-protective role
for human kallikrein-related peptidase 6 in breast cancer mediated
by inhibition of epithelial-to-mesenchymal transition. Cancer Res.
69:3779–3787. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Diamandis EP, Yousef GM, Soosaipillai AR
and Bunting P: Human kallikrein 6 (zyme/protease M/neurosin): A new
serum biomarker of ovarian carcinoma. Clin Biochem. 33:579–583.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shu Z, Chen L and Ding D: miR-582-5P
induces colorectal cancer cell proliferation by targeting
adenomatous polyposis coli. World J Surg Oncol. 14:2392016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang J, Li H, Wang Y, Wang L, Yan X, Zhang
D, Ma X, Du Y, Liu X and Yang Y: MicroRNA-552 enhances metastatic
capacity of colorectal cancer cells by targeting a disintegrin and
metalloprotease 28. Oncotarget. 7:70194–70210. 2016.PubMed/NCBI
|
|
24
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
de Vasconcellos JF, Byrnes C, Lee YT,
Allwardt JM, Kaushal M, Rabel A and Miller JL: Tough decoy
targeting of predominant let-7 miRNA species in adult human
hematopoietic cells. J Transl Med. 15:1692017. View Article : Google Scholar : PubMed/NCBI
|
